表紙
市場調査レポート

Northern Antibiotics Oy - 製品パイプライン分析

Northern Antibiotics Oy - Product Pipeline Review - 2015

発行 Global Markets Direct 商品コード 310647
出版日 ページ情報 英文 20 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.06円で換算しております。
Back to Top
Northern Antibiotics Oy - 製品パイプライン分析 Northern Antibiotics Oy - Product Pipeline Review - 2015
出版日: 2015年06月24日 ページ情報: 英文 20 Pages
概要

Northern Antibiotics Oyは、グラム陰性菌感染症の治療のための化合物を開発する研究開発企業です。主に、緑膿菌、グラム陰性腸内細菌、アシネトバクターに対する活動による化合物を提供しています。 同社はまた、国立抗菌・感染予防・血清学研究所と提携して研究・開発に力を入れています。

当レポートでは、Northern Antibiotics Oyにおける治療薬開発パイプラインの現況と各開発段階の比較分析、薬剤標的、作用機序、投与経路、分子タイプ別の治療薬の評価、最新の企業ニュースや発表、後期段階および中止されたプロジェクトに関する情報などを提供しています。

Northern Antibiotics Oyの基本情報

Northern Antibiotics Oyの概要

  • 主要情報
  • 企業情報

Northern Antibiotics Oy:R&Dの概要

  • 主な治療範囲

Northern Antibiotics Oy:パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品

Northern Antibiotics Oy:パイプライン製品の概況

  • 初期段階にあるパイプライン製品
    • 前臨床段階にある製品/併用療法モダリティ

Northern Antibiotics Oy:薬剤プロファイル

  • NAB-7061
  • NAB-739
  • NAB-741

Northern Antibiotics Oy:パイプライン分析

  • 標的別
  • 分子タイプ別
  • 作用機序別

Northern Antibiotics Oy:本社と子会社の所在地

付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC07168CDB

Summary

Global Markets Direct's, 'Northern Antibiotics Oy - Product Pipeline Review - 2015', provides an overview of the Northern Antibiotics Oy's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Northern Antibiotics Oy's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Northern Antibiotics Oy including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Northern Antibiotics Oy's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Northern Antibiotics Oy's pipeline products

Reasons to buy

  • Evaluate Northern Antibiotics Oy's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Northern Antibiotics Oy in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Northern Antibiotics Oy's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Northern Antibiotics Oy and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Northern Antibiotics Oy
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Northern Antibiotics Oy and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Northern Antibiotics Oy Snapshot
    • Northern Antibiotics Oy Overview
    • Key Information
    • Key Facts
  • Northern Antibiotics Oy - Research and Development Overview
    • Key Therapeutic Areas
  • Northern Antibiotics Oy - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Northern Antibiotics Oy - Pipeline Products Glance
    • Northern Antibiotics Oy - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Northern Antibiotics Oy - Drug Profiles
    • NAB-7061
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NAB-739
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NAB-741
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Northern Antibiotics Oy - Pipeline Analysis
  • Northern Antibiotics Oy - Pipeline Products by Target
  • Northern Antibiotics Oy - Pipeline Products by Molecule Type
  • Northern Antibiotics Oy - Pipeline Products by Mechanism of Action
  • Northern Antibiotics Oy - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Northern Antibiotics Oy, Key Information
  • Northern Antibiotics Oy, Key Facts
  • Northern Antibiotics Oy - Pipeline by Indication, 2015
  • Northern Antibiotics Oy - Pipeline by Stage of Development, 2015
  • Northern Antibiotics Oy - Monotherapy Products in Pipeline, 2015
  • Northern Antibiotics Oy - Preclinical, 2015
  • Northern Antibiotics Oy - Pipeline by Target, 2015
  • Northern Antibiotics Oy - Pipeline by Molecule Type, 2015
  • Northern Antibiotics Oy - Pipeline Products by Mechanism of Action, 2015

List of Figures

  • Northern Antibiotics Oy - Pipeline by Top 10 Indication, 2015
  • Northern Antibiotics Oy - Pipeline by Top 10 Molecule Type, 2015
Back to Top